Registry study for people with rare or advanced cancers
Part of Cancer clinical trials.
This is a study that collects information about people with rare cancers (or cancers where the source is unknown) and advanced-stage cancer. It helps researchers build a knowledge database to improve understanding and care for these cancers in Asia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis (biopsy/pathology) of a rare cancer or an unusual cancer type
- Your cancer is considered advanced stage
- Your cancer may be from an unknown primary site or a rare type within a common cancer
- You do not have complications that significantly affect memory or thinking (cognitive impairment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health and treatment information from people with breast cancer that cannot be fully removed by surgery or that has spread to other parts of the body. It may help researchers better understand which treatments are used and how people do over time.
This study enrolls people who have (or might have) cancer so the researchers can collect genetic and treatment information. The goal is to better understand how different cancers behave and how people respond to treatment, which may help improve future care.
This study collects information about people with rare cancers in Korea to better understand these diseases. It may help improve future care and treatments.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
This real-world study follows adults in Canada who have cancer that was tested and found to have rare molecular (DNA/protein) changes. It helps researchers understand how these rare findings show up and how care happens in everyday practice.
Hear when a new Rare Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.